Logo

American Heart Association

  1
  0


Final ID: WP332

Association between Neurological Complications and Carotid-cerebral Artery Disease after Coronary Artery Bypass Grafting

Abstract Body: Objective:To investigate the epidemiology of carotid-cerebral artery disease in coronary artery bypass grafting (CABG) patients and explore the influence of different degrees of carotid-cerebral artery disease on postoperative neurological complications.
Method:We prospectively collected and analyzed 1002 consecutive patients who underwent CABG between March 2020 to November 2022 in our single center. Computed tomography angiography (CTA) was performed preoperatively. Patients were then divided into two cohorts with or without carotid-cerebral artery disease (defined as stenosis of any carotid, vertebral or intracranial artery≥50%). The primary outcome was the early neurological complications (within 7 days post-CABG), defined as a composite of stroke, delayed awakening (≥48h after withdrawing sedative), and severe delirium (ICU CAM-II score≥2).
Results:Of the overall 1002 patients, the most susceptible arteries of stenosis≥50% were internal carotid artery(34.2%, 686/2004). vertebral artery (19.5%, 390/2004). and common carotid artery (17.3%, 347/2004). Basilar artery (2.3%, 23/1002) was the least affected. Extracranial lesions were present in 77.9%(781/1002) of patients, intracranial lesions in 35.7%(358/1002) and both intracranial and extracranial lesions in 32.2%(323/1002). Early neurological complications post-CABG occurred in 104 patients (10.4%), including 16(1.6%) with stroke, 45(4.5%) with delayed awakening and 60(6.0%) with severe delirium. Patients with carotid-cerebral artery disease had a higher risk of appearing early neurological complications (risk ratio [RR], 2.09; 95% CI, 1.39-3.13), stroke (RR, 3.66; 95% CI, 1.05-12.78), delayed awakening (RR, 1.87; 95% CI, 1.01-3.48), severe delirium (RR, 1.97; 95% CI, 1.15-3.38). Patients with carotid-cerebral artery disease still increased the risk of early neurological complications (adjusted RR, 1.66; 95% CI, 1.10-2.51) after adjustment possible confounders. As the degree of carotid-cerebral artery disease increased, there was a statistically significant linear upward trend in the incidence of all primary outcomes (P<0.05 for all).
Conclusions:The combined carotid-cerebral artery disease was common in CABG patients, with the internal carotid artery, vertebral artery and common carotid artery being the most susceptible. Patients with carotid-cerebral artery disease was independently causally associated with early neurological complications after CABG.
  • Liu, Yi  ( Ruijin Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai , China )
  • Zhu, Yunpeng  ( Ruijin Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai , China )
  • Jin, Wei  ( Ruijin Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai , China )
  • Jin, Zhijia  ( Ruijin Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai , China )
  • Gu, Jianwei  ( Ruijin Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai , China )
  • Zhao, Qiang  ( Ruijin Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai , China )
  • Author Disclosures:
    Yi Liu: DO NOT have relevant financial relationships | Yunpeng Zhu: DO NOT have relevant financial relationships | Wei Jin: No Answer | Zhijia Jin: No Answer | Jianwei Gu: No Answer | Qiang Zhao: DO NOT have relevant financial relationships
Meeting Info:
Session Info:

Risk Factors and Prevention Posters I

Wednesday, 02/05/2025 , 07:00PM - 07:30PM

Poster Abstract Session

More abstracts on this topic:
Beat-to-beat Blood Pressure Variability, Cerebrovascular Reactivity, and White Matter Lesion Volume In Older Adults

Lohman Trevor, Wang Danny, Nation Daniel, Sible Isabel, Engstrom Allie, Kapoor Arunima, Shenasa Fatemah, Alitin John Paul, Gaubert Aimée, Nguyen Amy, Shao Xingfeng

Efficacy of a Glucagon-Like Peptide-1 Agonist in Patients undergoing Coronary Artery Bypass Grafting or Aortic Valve Replacement – a randomized clinical trial

Kjaergaard Jesper, Boesgaard Soeren, Kober Lars, Nilsson Jens Christian, Hassager Christian, Moeller Christian Holdflod, Wiberg Sebastian, Mikkelsen Astrid, Møller-sørensen Peter Hasse, Ravn Hanne Berg, Ravn Jesper, Olsen Peter Skov, Høfsten Dan

You have to be authorized to contact abstract author. Please, Login
Not Available

Readers' Comments

We encourage you to enter the discussion by posting your comments and questions below.

Presenters will be notified of your post so that they can respond as appropriate.

This discussion platform is provided to foster engagement, and simulate conversation and knowledge sharing.

 

You have to be authorized to post a comment. Please, Login or Signup.


   Rate this abstract  (Maximum characters: 500)